WASHINGTON — An at-home COVID-19 testing kit is being recalled for failing to meet FDA requirements. The lack of FDA approval means that there is not sufficient data demonstrating that the test's ...
Agreement supports development and availability of an affordable, high-quality enzyme deficiency test SEATTLE, June 21, 2018 /PRNewswire/ -- PATH announced today a new partnership with South Korean ...
South Korean billionaire Cho Young-sik’s SD Biosensor and Seoul-based private equity firm SJL Partners said Thursday that they are acquiring Nasdaq-listed diagnostics company Meridian Bioscience for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback